文献速递神经肿瘤

伽玛刀放射外科治疗术后残留脑膜瘤:按WHO分级分析复发因素

Gamma Knife Radiosurgery for Postoperative Remnant Meningioma: Analysis of Recurrence Factors According to World Health Organization Grade.
PubMed 文献 · World Neurosurg · 2019-08-30

该回顾性研究纳入2007年至2017年218例接受伽玛刀放射外科(GKS)治疗的术后残留脑膜瘤患者,平均随访37.4个月,13例(5.9%)出现复发。组织学分级与复发显著相关(P < 0.001),高级别(WHO II和III级)脑膜瘤复发率达32%。复发模式多位于50%边缘剂量野附近,提示精准靶区定义的重要性。

要点

  • GKS治疗后残留脑膜瘤总体复发率为5.9%,平均随访37.4个月。
  • WHO II和III级脑膜瘤复发率高达32%,组织学分级与复发显著相关(P < 0.001)。
  • 多数复发位于50%边缘剂量野附近,强调精准靶区定义的必要性。

核心结论

  • 术后残留脑膜瘤GKS治疗后复发与恶性组织学特征相关,高级别肿瘤复发风险高。
  • 复发模式提示需精确界定GKS靶区以减少边缘复发。

研究设计与样本

  • 回顾性分析2007年1月至2017年1月218例接受GKS治疗的术后残留脑膜瘤患者。
  • 比较GKS前与随访MRI评估复发,分析组织学分级及临床特征(性别、年龄、肿瘤位置、靶体积、处方剂量)。

主要发现

  • 218例中13例(5.9%)在平均37.4个月随访期内出现复发。
  • 复发模式:9例位于50%边缘剂量野邻近,2例位于野内,2例位于野外。
  • WHO I级196例中6例复发,II级20例中6例复发,III级2例中1例复发;高级别(II和III级)复发率32%。
  • 组织学分级与复发显著相关(P < 0.001)。

临床怎么用

  • 对术后残留脑膜瘤行GKS时,应依据组织学分级评估复发风险,高级别肿瘤需更密切随访。
  • 靶区定义应精确,尤其注意50%边缘剂量野的覆盖,以减少边缘复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The effectiveness of tumor control after Gamma Knife radiosurgery (GKS) for intracranial meningioma is well established. Moreover, GKS is an alternative to reduce surgical-remnant meningioma recurrence. Nevertheless, the tumor can recur even after GKS and is associated with its histologic malignancy. We here investigated the risk factors associated with recurrence from remnant lesions after GKS, assessing recurrence patterns according to histological grades. METHODS: From January 2007 to January 2017, 218 patients underwent GKS for surgical-remnant lesions. To evaluate post-GKS lesion recurrence, pre-GKS magnetic resonance images were compared with those at follow-up. We retrospectively analyzed the histologic classification of meningioma and patients' clinical characteristics (sex, age, tumor location, target volume, and prescription dose). RESULTS: Of the 218 patients, 13 (5.9%) developed post-GKS recurrence within a mean follow-up period of 37.4 months. The recurrence patterns were as follows: adjacent to the 50% marginal-dose field (9 patients); within the 50% marginal-dose field (2 patients); and outside the field (2 patients). Six of 196 World Health Organization grade I meningioma cases, 6 of 20 grade II cases, and 1 of 2 grade III cases developed recurrence. Thus 32% of high-grade meningioma cases (grades II and III) developed recurrence during the follow-up period. Histologic grade was significantly associated (P < 0.001) with recurrence. CONCLUSIONS: The study findings indicate that the post-GKS meningioma recurrence likelihood is high when the meningioma has malignant histologic features. In addition, considering the recurrence patterns, it is important to define a precise target for GKS.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Park CK, Jung NY, Chang WS, et al. Gamma Knife Radiosurgery for Postoperative Remnant Meningioma: Analysis of Recurrence Factors According to World Health Organization Grade. World Neurosurg. 2019. PMID: 31476462. doi:10.1016/j.wneu.2019.08.136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。